Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2115-2118

  Kawahara, Hidejiro ^a   Watanabe, Kazuhiro ^a   Toyama, Yoichi ^a   Yanagisawa, Satoru ^a   Kobayashi, Susumu ^a   Yanaga, Katsuhiko ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Circulating tumor cell; Colorectal cancer; Prediction of progression

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; OXALIPLATIN; PANITUMUMAB;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; MALE; METASTASIS; ONCOGENE K RAS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOEMBRYONIC ANTIGEN; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; ORGANOPLATINUM COMPOUNDS; OXONIC ACID; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84870652346     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11970     Document Type: Article

References (12)

1. Ashworth TR: A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 1869; 14:146-149.
2. Japanese society for cancer of the colon and rectum: Japanese classification of colorectal carcinoma. 2nd English Ed. Kanehara Co Ltd, Tokyo, 2009.
3. McNiece I, Brddell R, Stoney G, et al.: Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997; 6:5-11.
4. Neurauter AA, Bonyhadi M, Lien E, et al.: Cell isolation and expansion using Dynabeads. Adv Biochem Eng Biotechnol 2007; 106:41-73.
5. Peters CE, Woodside SM, Eaves AC: Isolation of subsets of immune cells. Methods Mol Biol 2005; 302:95-116.
6. Lankiewicz S, Rivero BG, Bocher O: Quantitive real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol Biotechnol 2006; 34:15-27.
7. Allard WJ, Matera J, Miller MC, et al.: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant disease. Clin Cancer Res 2004; 10:6897-6904.
8. Cohen SJ, Alpaugh RK, Gross S: Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2006; 6:125-132.
9. Allen-Mersh TG, McCullough TK, Patel H, et al.: Role of circulating tumor cells in predicting recurrence after excision of primary colorectal carcinoma. Br J Surg 2007; 94:96-105.
10. Cohen SJ, Punt CJ, Iannotti N, et al.: Relationship of circulating tumor cells to tumor response, progression-free survival and overall survival in patients with metastatic colorectal cancer. J ClinOncol 2008; 26:3213-3221.
11. Cohen SJ, Punt CJA, Lannotti N, et al.: Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 2009; 20:1223-1229.
12. Yalcin S, Kilickap S, Portakal O, Arslan C, Hascelik G, Kutluk T: Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence. Hepato-Gastroenterol 2010; 57:1395-1398.